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 SUMMARY 
Nina Lukač: The role of the Fas/FasL apoptotic pathway on 
osteoclastogenesis in the mouse model of controlled tibial fracture 
 
Key words: bone, Fas, FasL, fracture, osteoclast 
 
The Fas/FasL apoptotic system serves as a regulator of the immune system, 
but also has an influence on osteoclast survival and differentiation. The model 
of internally fixated controlled tibial fractures was used to evaluate its role on 
osteoclastogenesis in formation of new bone, as fracture healing serves as a 
model for embryonic skeletal development. The aim of this study was to 
evaluate the role of the apoptotic system on osteoclastogenesis in vivo, by 
evaluating the osteoclastogenic potential of different tissues; and in vitro, by 
analyzing the numbers of osteoclasts and eroded surface on histological 
sections of tibiae. The roles of Fas and FasL were investigated using 
knockout mice for the receptor and its ligand. We hypothesized that the 
number of osteoclasts would increase in the knockout strains because of a 
lacking of osteoclast apoptosis when Fas/FasL pathway is not functioning.  
Observation of the histological sections of calluses in fractured tibiae 
confirmed that the healing of the fracture occurred by endochondral 
ossification. Our results showed that the loss of Fas or FasL caused an 
increase in the number of osteoclasts and the eroded surface in fracture 
calluses in the second week after the fracture, which was not observed in the 
B6 control. The analysis of osteoclasts on cartilage surfaces showed that the 
loss of Fas or its ligand did not cause a change in the number of osteoclasts 
on the cartilaginous part of the callus in the second week and did not cause a 
difference between the osteoclast numbers on the growth plate cartilage. The 
number of osteoclasts on those two cartilage surfaces did not differ between 
each other as well.  
These results show that the Fas/FasL apoptotic system has a role in 
osteoclastogenesis during new bone formation, but further research is 
necessary to further elucidate its exact function. 
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PREFACE 
1. Bone 
Bone is the main component of the adult skeleton, which serves, among other 
roles, as the body’s mechanical support. It also protects internal organs and 
the brain and provides attachment sites for muscles and leverage, both of 
which give body mobility. It stores approximately 99% of body’s calcium and 
85% of phosphate and thus serves as their main mineral reservoir. Bones 
contain a central medullary cavity, which harbors bone marrow, the main 
hematopoietic organ. It stores many cytokines and growth factors. 
Based on their shape, bones can be classified as short, long and flat. Two 
types of bone can be differentiated based on gross observation: 1) compact 
(or cortical bone), the outer region located below periosteum; and 2) 
trabecular (also called cancellous or spongy) bone, the inner part which is 
made of interconnected trabeculae and lined by endosteum. 
2. Osteoblasts, osteoclasts, and bone matrix 
Histologically, bone is classified as connective tissue and is composed of the 
bone matrix and different cell types. Internal and external surfaces of the bone 
are lined by endosteum and periosteum. Both are made of dense connective 
tissue, containing collagen and fibroblasts and on places where the lining is in 
contact with underlying bone also of osteoblasts and osteoprogenitor cells.  
Derived from mesenchymal progenitor cells, osteoblast are mononuclear cells 
that are responsible for synthesis of bone matrix (Ducy et al. 2000). As they 
secrete the organic components, collagen type 1, proteoglycans and 
glycoproteins, they are of cuboidal shape, but they flatten as their synthetic 
activity declines. As the deposited matrix progressively surrounds them, they 
become osteocytes, encased in lacunae, and acquire dendritic processes that 
are enclosed in canaliculi. Osteoblast are also responsible for control of 
function of osteoclasts, the other important cell found in the bone, which is 
described separately in the next paragraph. The bone matrix is composed of 
inorganic part, hydroxyapatite crystals (Ca10(PO4)6(OH)2) and organic part. 
The organic matter is made mostly of collagen type 1, but also contains 
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glycoproteins and proteoglycans. The matrix is a place harboring many 
cytokines and growth factors. 
Osteoclasts are cells of hematopoietic origin, responsible for bone resorption. 
Their mononuclear marrow-derived progenitors are recruited to areas of bone 
resorption, where they acquire their characteristic multinuclear appearance by 
cell fusion. They reside in so-called Howship’s lacunae or resorption bays in 
the bone, where they adhere to the bone to create an isolated space of 
resorptive environment between them and the bone matrix. A hallmark of an 
active osteoclast, the ruffled border, is responsible for secreting molecules 
needed for degradation and resorption of the bone.  
Major regulators of osteoclast proliferation, survival and differentiation are 
RANKL (receptor activator of nuclear factor κB ligand)(Teitelbaum 2000) and 
M-CSF (macrophage-colony stimulating factor)(Felix et al. 1990). RANKL is a 
type 2 membrane protein belonging to TNF superfamily that is expressed on 
osteoblasts and acts through its receptor RANK (receptor activator of nuclear 
factor κB). Both osteoclast precursors and mature osteoclasts express RANK 
(Dougall et al. 1999). Ligand binding leads to activation of several signaling 
pathways: NFATc1, NF-kB, Akt/PKB, JNK, ERK, and p38 (Feng 2005). 
RANKL/RANK system has a negative regulator – OPG (osteoprotegerin) that 
is secreted from osteoblasts and acts as RANKL’s decoy receptor (Lacey et 
al. 1998). M-CSF, the other critical molecule for osteoclast development, 
mediates proliferation and survival of osteoclast precursors by binding to the 
receptor CSF1R (colony-stimulating factor-1 receptor) (Stanley et al. 1997). 
Many other cytokines and growth factors have been linked to osteoclast 
regulation, including GM-CSF (Lee et al. 2009), IL-3 (Khapli et al. 2003), IL-1 
(Kim et al. 2009), TNF-α (Kwan Tat et al. 2004) and other members of the 
TNF superfamily including FasL (Katavic et al. 2003, Wu et al. 2003). 
Bone is highly metabolically active and undergoes constant changes by 
coordinated activity of osteoblasts and osteoclasts, which yearly replace 
approximately 10% of the adult skeleton (Kolar et al. 2010). This simultaneous 
activity of bone formation and resorption is called coupling (Kelava et al. 
2014). 
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3. Bone development 
Osteogenesis, the process of bone development, can occur by two 
mechanisms – endochondral or intramembranous ossification, depending on 
whether it occurs in long or flat bones, respectively. In both, bone tissue 
develops from mesenchyme; in intramembranous ossification this change 
occurs directly from mesenchymal progenitors into osteoblasts that start 
secreting bone matrix whereas in endochondral ossification, the mesenchyme 
first develops into hyaline cartilage, which is later invaded and replaced by 
osteoblasts. Long bones develop by endochondral ossification. Mesenchymal 
cells become committed to the cartilage lineage, condense and differentiate 
into chondrocytes. They proliferate and secrete extracellular matrix to make a 
model of the bone. Chondrocytes become hypertrophic, compress 
surrounding matrix and die by apoptosis, leaving empty space which is 
invaded by blood vessels that bring osteoprogenitor cells. In the diaphysis, 
this forms the primary ossification center, while secondary ossification centers 
appear later in epiphyses. (Gilbert 2000, Mescher 2013) 
4. Fracture healing 
Fractures are the most common injuries caused by trauma in humans 
(Einhorn & Gerstenfeld 2015) and their healing differs from wound healing, 
because it does not result in scar formation but usually restores tissue to its 
previous form (McKibbin 1978). Being relatively easy to reproduce, they are 
an ideal model for studying complex events occurring during bone tissue 
regeneration and embryological development of the skeleton (Hadjiargyrou & 
O'Keefe 2014).  
Fracture healing proceeds through three phases: inflammatory, proliferative 
and remodeling phase. Hematoma formation due to tissue damage during 
fracture, which leads to inflammatory responses, is the starting point of the 
fracture healing cascade (Kolar et al. 2010). Cytokines and growth factors 
from the injury response are responsible for activation of osteoprogenitor cells 
that originate mainly from the periosteum (Hadjiargyrou & O'Keefe 2014). 
Healing in the center of fracture calluses will follow the steps of endochondral 
ossification, where progenitors will first develop into chondrocytes and form 
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the soft callus, but then hypertrophy and die and become replaced by 
osteoblasts (Claes et al. 2012). In the remodeling phase, osteoclast remove 
newly formed matrix, while osteoblast are continually laying down new bone, 
and this coupled processes leads to the reestablishment of previous bone 
architecture and continuity with the adjacent uninjured area (Einhorn & 
Gerstenfeld 2015). 
5. Fas/FasL system 
5.1. Role and expression  
Fas (APO-1, CD95) and its ligand, FasL (APO-1L, CD95L) are both members 
of the TNF (tumor necrosis factor) family and are well known mediators of 
apoptosis in multiple cell types. They induce apoptosis via the extrinsic or the 
death receptor pathway (Wajant 2002). They are involved in regulation of the 
immune response – they reduce excess immune system activation, play a 
role in removal of autoreactive T lymphocytes and mediate some effects of 
cytotoxic T lymphocytes (Kavurma & Khachigian 2003). Fas is a type 1 
transmembrane protein that is activated upon binding of its ligand (FasL), a 
type 2 membrane protein, to trigger a cascade of downstream signaling which 
ultimately leads to cell death. Even though it has mostly been seen as the 
mediator of apoptosis, non apoptotic functions of the death receptor have also 
been described (Peter et al. 2007, Park et al. 2005a). Its expression has been 
found on cells of the immune system, heart, liver, kidney, pancreas and brain, 
while FasL, is not found on as many cells – its expression is confined mostly 
to cells of the immune system, cells in the anterior chamber of the eye, Sertoli 
cells in testis and placenta, where it may contribute to maintenance of 
immune privilege (Kayagaki et al. 1997, Kovacic et al. 2010a).  
 
The role of the Fas system has been studied on mice models with 
spontaneous Fas or FasL mutation (lpr and gld mice, respectively), on 
knockout mice (Fas-/- and FasL -/-) and cell specific or conditional knockout 
mice of both receptor and its ligand. Lpr (lymphoproliferation) and gld 
(generalized lymphoproliferative disease) mice develop autoimmune 
manifestations and lymphadenopathy (Takahashi et al. 1994) and are mice 
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models for systemic lupus erythematosus and Sjögren syndrome. Incomplete 
penetrance of the Fas or FasL deficient phenotype has been suspected for 
both gld and lpr mutation and has been proven in lpr mice (Kovacic et al. 
2010a, Kovacic et al. 2007, Mariani et al. 1994). 
Fas mutation has also been described in human, leading to autoimmune 
lymphoproliferative syndrome (ALPS), which presents with chronic 
nonmalignant lymphadenopathy or splenomegaly, autoimmune disease and 
an increase in CD3+CD4-CD8- (double negative) T lymphocytes (Fisher et al. 
1995, Sneller et al. 2003). 
5.2. Role of Fas/FasL system in bone 
Fas and FasL expression has also been found on bone cells. Both murine 
osteoblasts and osteoclasts have been found to express Fas and FasL, but 
the level of expression differs with the level of cell differentiation and between 
different studies (Kovacic et al. 2010a). While Fas expression was confirmed 
on osteoblasts, where it increases with their level of differentiation (Kovacic et 
al. 2007), reports about its expression on osteoclasts are contrasting – some 
data suggest weak expression (Kovacic et al. 2007), while others describe a 
strong expression (Wu et al. 2003). 
The role of Fas and its ligand in osteoclast development, survival and 
apoptosis has been described in a number of studies. Some studies show that 
the Fas/FasL system is involved in mediating osteoclast apoptosis (Wu et al. 
2003, Roux et al. 2005, Wang et al. 2015) and that a mutation in Fas or FasL 
will increase numbers of osteoclast cells on bone surfaces (Wu et al. 2003). 
Another study showed only a weak increase in apoptotic osteoclast when 
FasL was added to cultures (Kovacic et al. 2007). It has also been established 
that the Fas system is involved in prevention of development of osteoporotic 
phenotype after estrogen withdrawal in mice (Katavic et al. 2003, Kovacic et 
al. 2010b, Nakamura et al. 2007, Tang et al. 2014), and that loss of Fas 
(Kovacic et al. 2010b) or FasL (Katavic et al. 2003) protects mice from 
ovariectomy-induced bone loss. Estrogen has also been shown to increase 
FasL expression on osteoclasts (Nakamura et al. 2007). Park et al showed 
that interaction between Fas and FasL increases osteoclastogenesis (Park et 
al. 2005b). When bone mass was examined in mice with spontaneous 
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mutation for FasL and Fas, gld (generalized lymphoproliferative disorder) and 
lpr (lymphoproliferative syndrome) mice respectively, the results showed 
increased bone mass of gld mice compared to their wild type controls and 
decreased numbers of osteoclasts on bone surfaces (Katavic et al. 2003). Wu 
et al showed a significant decrease in lpr and an insignificant slight decrease 
in gld mice bone mass, with an increased osteoclast/bone surface number, 
however, sex and age of mice were different between the two experiments 
(Wu et al. 2003). Besides directly causing osteoclast apoptosis, the effects of 
Fas system on number of osteoclasts were also suggested to be mediated 
indirectly through osteoblasts, by influencing their survival and thus controlling 
the OPG/RANKL ratio which is dependent upon level of osteoblast 
development (Katavic et al. 2003). 
When fracture healing was studied in lpr mice, Fas deficiency prolonged the 
cartilage resorption period, which was later followed by a decrease in 
mineralized tissue in callus of the Fas deficient (lpr) mice, when compared to 
wild type control. This was attributed to higher rates of bone turnover in lpr 
mice supported by the fact that lpr mice had higher number of osteoclasts per 
bone surface (Al-Sebaei et al. 2014). 
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HYPOTHESES 
Loss of function of the Fas/FasL apoptotic system will cause an increased 
number of osteoclasts on bone surfaces in vivo, due to the lack of the 
apoptotic pathway and consequently longer survival of osteoclasts. 
 
We hypothesized that in vitro the osteoclastogenic capacity of mononuclear 
progenitor cells would be increased in animals lacking the Fas/FasL pathway 
at all time points in comparison to wild type control. 
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OBJECTIVES 
It has been previously described that the Fas/FasL apoptotic system, apart 
from acting as a regulator of the immune response, plays a role in regulation 
of bone formation, remodeling and resorption and has an influence on 
osteoclast life span and differentiation (Katavic et al. 2003, Wu et al. 2003, 
Roux et al. 2005, Wang et al. 2015, Park et al. 2005b).  
Fracture healing is a recapitulation of many of the embryonic processes that 
occur in bone formation (Ferguson et al. 1999) and is an ideal model for 
studying the complex cellular and molecular interactions and temporal 
relations of events occurring during skeletogenesis. 
The objective of this study were: 
1) to evaluate the role of the Fas/FasL apoptotic system on 
osteoclastogenesis in vivo and 
2) to evaluate the role of the Fas/FasL apoptotic system on 
osteoclastogenesis in vitro. 
This was studied in a murine model of controlled tibial fracture, internally 
fixated by a stainless steel wire. Our goal was to analyze the influence of the 
Fas/FasL system on osteoclast numbers on bone surfaces in fractured and 
non-fractured tibiae (in vivo) and asses its influence on the osteoclastogenic 
potential of marrow and peripheral blood mononuclear progenitors (in vitro). 
All analyses were done at different time points, at 1, 2 ,and 3 weeks after the 
fracture procedure, to provide an insight into the chronological order of 
events. 
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MATERIALS AND METHODS 
1. Experimental animals 
Animals used in the experiment were male 12-14 week old Fas (Fas -/-) and 
FasL (FasL -/-) knockout mice and their age and sex matched wild type 
C57BL/6J controls (B6). Both knockout strains were on the C57BL/6J 
background. Animals were randomly allocated into three groups – a “fracture” 
group (described lower), a “pin control” group’ (no fracture performed, but a 
steel wire for internal fixation was introduced into the medullary cavity), and a 
“control” group (no fracture, no internal fixation), depending on the procedure 
that was performed. 
Mice were bred and housed at the Croatian Institute for Brain Research, 
University of Zagreb Medical School. Experiments were approved by the 
Ethics Committee of the University of Zagreb School of Medicine. 
2. Controlled tibial fracture 
Bilateral transverse closed tibial fractures were performed according to a 
protocol originally described previously (Bonnarens & Einhorn 1984). Briefly, 
the fractures were done in 12-14 week old experimental mice anesthetized 
with AVERTIN (3-bromoethanol, Sigma Aldrich Corp.) after lubricating their 
eyes with bromine-vaselin ointment. The protocol was modified and approved 
by the Animal Care and Use Committee, University of Conneticut Health 
Center (CT), USA, where members of our laboratory were educated for the 
before mentioned procedure.  
Before the fracture, a 25G bore needle was inserted into the medullary cavity 
through the tibial plateau. After retracting the needle, a stainless steel wire 
with 0,5 mm diameter was inserted into the same canal, to fixate bone 
fragments after the fracture. The fracture was done 1-2 mm proximal of the 
distal fibular attachment with minimal fragment movement, using a device 
composed of a fixation table and dull steel blade, according to the described 
protocol (Bonnarens & Einhorn 1984). After the procedure, mice were warmed 
on a warm electric mat. The animals were examined every 30 minutes after 
the operation (4 clinical examinations in 2 hours) and in case of appearance 
of signs of terminal illness (loss of body weight, loss of righting reflex, loss of 
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reaction to external stimuli), the animal was immediately euthanized by 
cervical dislocation.  
Controlled tibial fracture was not done on mice of the pin control group 
(sham); those animals differed from the experimental group only by this part 
of the procedure. Mice of the pin control group were anesthetized, their eyes 
were lubricated by bromine-vaseline ointment, a stainless steel wire with 0,5 
mm diameter was inserted into the tibial medullary canal, and after that they 
were warmed on a warm electric mat and examined every 30 minutes after 
anesthesia. In case of appearance of signs of terminal illness, the animal was 
immediately euthanized by cervical dislocation.  
Mice were clinically evaluated every day and their behavior, changes in 
movement, existence of tremor, changes on the eyes and visible mucosa, 
general condition and posture, dyspnea/tachypnea, dehydration, loss of body 
mass and shape and emergence of stereotypies were recorded. Analgesic 
therapy was introduced when needed based on this assessments. 
Mice were sacrificed 1, 2, and 3 weeks after the initial procedure with cervical 
dislocation after exposure to a lethal dose of the anesthetic. Fractured bones 
were put into fixative and the number of osteoclasts was analyzed on different 
bone and cartilage surfaces. Blood from the orbital plexus and bone marrow 
from femurs and tibiae were obtained from the animals for in vitro evaluation 
of the osteoclastogenic potential of those tissues. 
3. Histological analysis 
Changes in the number of osteoclasts per bone surface, percent of eroded 
surface, and number of osteoclasts on the surface of cartilage tissue in 
fracture callus and on epiphyseal hyaline cartilage were analyzed by 
histological analysis of tibiae 1, 2, and 3 weeks after the fracture or sham 
procedure. 
Tibiae, fractured and those from the pin-control groups, were obtained from 
the animals after they were sacrificed. Attached soft tissue, as well as the 
intramedullary pin, were removed and the bones were then fixated in 4% 
paraformaldehyde for 24 hours. They were then demineralized in a 3% 
formalin in 14% EDTA solution for 2 weeks. Ascending concentrations of 
ethanol (70%, 96%, and 100%) were used to dehydrate the specimens which 
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were then embedded in paraffin. Sections 7 m thick were made using a 
Leica RM 2135 rotary microtome (Leica, Nussloch, Germany). Tissues were 
histochemically stained for tartrate-resistant acid phosphatase (TRAP) 
enzyme activity for osteoclast identification and with Goldner-trichrome stain. 
TRAP positive cells adjacent to bone surfaces were considered as osteoclasts 
and counted on two cuts per bone. Results were expressed as number of 
osteoclasts per bone or cartilage surface, and percent of eroded bone 
surface. Osteoclasts were counted on the surfaces of trabecular bone, below 
cortical bone, and on areas adjacent to the hyaline cartilage in the epiphyseal 
plate, and on the cartilaginous fracture callus. Analysis was performed under 
100× magnification with Zeiss Axio Imager microscope (Carl Zeiss, 
Oberkochen, Germany) connected to a computer with OsteoMeasure 
software (OsteoMetrics, Decatur, GA, USA). 
4. Analysis of osteoclastogenic potential 
Hematopoietic cells were obtained from bone marrow and peripheral blood of 
animals at 1, 2, and 3 weeks after the fracture or sham procedure, depending 
on whether the animal belonged to the ‘fracture’ or ‘pin control’ group, 
respectively. Cells were also obtained from the ‘control’ group. To analyze the 
osteoclastogenic potential of those tissues, osteoclast cell cultures were made 
from obtained cell suspensions, by inducing osteoclastogenesis with addition 
of RANKL and M-CSF.  
4.1. Bone marrow 
For obtaining bone marrow cell suspension, mice were sacrificed by cervical 
dislocation after being exposed to a lethal dose of anesthetic. Femurs and 
tibiae were removed and cleared of adherent soft tissues. Intramedullary steel 
wires were removed form tibiae. To obtain bone marrow cells, bone ends 
were cut and medullary cavities were flushed with minimum essential 
medium-  ( -MEM) (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) 
with a 23G needle. Cell suspensions were centrifuged at 1500RPM for 5 
minutes at 4°C. Supernatant was discarded and remaining cell pellet 
resusupended in 3ml -MEM with 10% fetal bovine serum (FBS) (Gibco, 
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Thermo Fisher Scientific, Waltham, MA, USA), 100 U/ml penicillin – 
streptomycin (Gibco, Thermo Fisher Scientific, Waltham, MA, USA) and 2mM 
GlutaMAXTM (100×, Gibco, Thermo Fisher Scientific, Waltham, MA, USA) for 
suspension form tibiae and 5ml for femur and filtered through a 40 m nylon 
cell strainer. Cells were stained with Türk solution and counted in Bürker-Türk 
chamber, then cultured overnight in an incubator at 37°C and 5% CO2 at 
density of 10×106 cells in 60x15mm tissue culture dish in 5ml -MEM 
containing 10% FBS, 100 U/ml penicillin–streptomycin, 2mM GlutaMAXTM and 
5ng/ml recombinant mouse (rm) M-CSF (R&D Systems, Minneapolis, MN, 
USA). On the next day, nonadherent cells were collected and centrifuged like 
the day before. Medium was removed, new suspension was made in 1ml of 
medium supplemented as described above and cells were counted again. 
Cells were cultured in 96 well plate at density 0,25×106 cell in 0,2ml -MEM 
with 10% FCS, 100 U/ml penicillin–streptomycin, 2mM GlutaMAXTM per well. 
20ng/ml rmM-CSF and 40ng/ml rmRANKL (R&D Systems, Minneapolis, MN, 
USA) were added to stimulate osteoclast differentiation. 
4.2. Peripheral blood 
Blood samples for cell suspension were obtained from orbital sinus, while 
mice were anesthetized with 3-bromoethanol (Avertin). The animal was 
placed on a flat surface, jugular vein was compressed right below the 
mandible and upper eyelid retracted to create mild exophthalmos. Glass 
capillary tube was introduced into medial angle of the eye and turned axially, 
to penetrate the wall of orbital sinus. Blood was put into test tube containing 
0,5ml of 8mM ethylenediamine tetracetic acid (EDTA) solution in phosphate-
buffered saline (PBS) at pH 8. 1,3 mL of 2% dextran solution in PBS was 
added to test tubes, to separate the blood cells. Suspension was incubated 
for 45min at 37°C and clear supernatant was collected until the border with 
erythrocyte sediment. Suspension was then made by adding -MEM with 
10% FBS, 100 U/ml penicillin–streptomycin, 2mM GlutaMAXTM to the 
collected supernatant. It was centrifuged as described above, supernatant 
medium removed and 2ml of new medium were added. Cells were counted 
and cultured in 96 well plate at density 0,25x106 cell in 0,2ml -MEM with 
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10% FCS, 100 U/ml penicillin – streptomycin, 2mM GlutaMAXTM per well with 
20ng/ml rmM-CSF and 40ng/ml rmRANKL to stimulate osteoclast 
differentiation. 
Medium was changed on day 3 and cells were fixed and stained day 5. 
Fixation was achieved by adding 2,5% glutaraldehyde in PBS for 30 minutes 
at room temperature and cells were stained using leukocyte acid phosphatase 
(TRAP) staining kit (Sigma Aldrich Corp., St Louis, MO, USA) according to 
manufacturer’s protocol. Cells that stained positively for TRAP and had three 
or more nuclei were considered osteoclasts and counted per well with Zeiss 
Axiovert 200 microscope (Carl Zeiss, Oberkochen, Germany) under 40× 
magnification. 
5. Statistical analysis 
Results are presented as mean value +/- standard deviation (SD) and groups 
were compared by Student’s t-test for two group comparison and one way 
ANOVA for three group comparison. Post hoc Tukey test was done to 
determine pairwise differences on the groups that showed significant 
differences with one way ANOVA. Differences between compared groups 
were considered statistically significant at p value lower than 0,05. Statistical 
analysis was done on MedCalc for Windows, version 14.0 (MedCalc 
Software, Ostend, Belgium).  
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RESULTS 
1. Analysis of osteoclastogenic potential 
In this part of the experiment, we analyzed the osteoclastogenic potential of 
mononuclear hematopoietic progenitors, derived from peripheral blood or 
bone marrow of femur or fractured tibia. Samples were obtained at 1, 2, or 3 
weeks following the fracture procedure. Osteoclastogenic potential was 
evaluated in vitro, by examining the number of osteoclasts that differentiated 
from the progenitors in osteoclast cell cultures. Osteoclast differentiation was 
stimulated by rmM-CSF and rmRANKL addition into the culture medium and 
TRAP positive cells with three or more nuclei were considered osteoclasts 
and counted per well under light microscopy. 8 wells per each group were 
cultured and results were presented as mean number of osteoclasts per 
group +/- standard deviation. 
 
Differences between osteoclastogenic potentials were examined at three 
different time points (week 1, week 2, and week 3) after the fracture 
procedure to evaluate how the loss of functional Fas receptor or its ligand, 
FasL changed the ability of progenitors to differentiate into mature osteoclasts 
from different target tissues (bone marrow of femur or fractured tibiae, and 
peripheral blood) when tibiae are fractured.  
In the third week after the fracture, we also compared osteoclastogenic 
potential of tissues obtained from mice which had the fracture procedure 
performed to those from control groups and mice who underwent the sham 
procedure (‘pin control’ group), to further evaluate how the tibial fracture 
influenced osteoclast differentiation from the bone marrow of tibiae and femur 
and peripheral blood in the three different strains. 
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1.1.  Effect of loss of functional Fas receptor or Fas ligand (FasL) on 
osteoclastogenic potential of bone marrow of tibiae 
In the first week after the fracture, cultures from B6 and FasL -/- mice had a 
higher number of osteoclasts per well than those from Fas -/- mice. In the 
second week, osteoclastogenic potential of B6 control group was higher than 
in both Fas -/- and FasL -/- mice derived cell cultures. Bone marrow of tibiae 
from Fas -/- and FasL -/- had the same osteoclastogenic potential as B6 
control 3 weeks after the fracture. (Figure 1) 
 
Osteoclastogenic potential of bone marrow of fractured tibiae was also 
compared with potential of marrow from tibiae of the control and pin control 
groups. In all three different strains (B6, Fas-/-, FasL-/-), the cell cultures from 
mice that had the fracture procedure performed, had a significantly lower 
number of osteoclasts per well as their control groups. In B6 and Fas -/- cell 
cultures, the number of osteoclasts in pin control groups was higher than in 
control and fracture groups. In FasL -/-, there was no significant difference 
between control and pin control group. (Figure 2) 
Results show that the fracture procedure caused a decrease in 
osteoclastogenic potential of the bone marrow of the fractured tibiae, when 
compared to the control group.  
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Figure 1. Osteoclastogenic potential of cells from bone marrow of fractured tibiae 1, 2, 
and 3 weeks after the fracture. Cell suspensions were made by combining bone marrow of 
tibiae of 2 mice per strain. Cells were cultured in 96 well plate at density 0,25×10
6
 cell per 
well. 20ng/ml rmM-CSF and 40ng/ml rmRANKL were added to stimulate osteoclast 
differentiation. A. Number of osteoclasts per well is presented as mean +/- standard deviation 
B, C & D. Morphology of osteoclast cell cultures in the first (B), second (C), and third (D) 
week after the fracture under 100× magnification. Osteoclasts are TRAP positive (purple) 
cells with 3 or more nuclei. * denotes a statistically significant difference at p <0,05. 
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Figure 2. Osteoclastogenic potential of cells from bone marrow of tibiae three weeks 
after the fracture (‘FR’), sham procedure (‘PIN CONTROL’) or in control group in B6, 
Fas -/-, and FasL -/- mice. Cell suspensions were made by combining bone marrow of tibiae 
of 2 mice per strain. Cells were cultured in 96 well plate at density 0,25×10
6
 cell per well. 
20ng/ml rmM-CSF and 40ng/ml rmRANKL were added to stimulate osteoclast differentiation. 
Number of osteoclasts per well is presented as mean +/- standard deviation. * denotes a 
statistically significant difference at p <0,05. 
1.2.  Effect of loss of functional Fas receptor or Fas ligand (FasL) on 
osteoclastogenic potential of bone marrow of femur  
In the first week after the tibial fracture, bone marrow cells from femur from B6 
control group had higher osteoclastogenic potential than those from Fas-/- 
and FasL-/-. In the second week, Fas-/- still had lower osteoclastogenic 
potential than B6 control group but the number of osteoclasts per well in 
FasL-/- group was higher than in both of the previously mentioned. In the third 
week B6 control had a higher number of osteoclasts per well than FasL-/-. 
(Figure 3) 
When the number of osteoclasts per well was compared between the animals 
with fractured tibiae and those from the control and pin control group, the 
number of osteoclasts that differentiated from the cells of bone marrow of 
femur in the mice that had their tibia fractured was lower than those in the 
control groups in tissue obtained from B6 control and FasL -/- mice. In bone 
marrow of femur of Fas -/- mice, there was no difference between the groups. 
Pin control group had a higher number of osteoclasts per well then the 
fracture group in FasL -/-, but the numbers did not differ in B6 control and Fas 
-/- (Figure 4).  
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Figure 3. Osteoclastogenic potential of cells from bone marrow of femurs 1, 2, and 3 
weeks after the fracture. Cell suspensions were made by combining bone marrow of femurs 
of 2 mice per strain. Cells were cultured in 96 well plate at density 0,25×10
6
 cell per well. 
20ng/ml rmM-CSF and 40ng/ml rmRANKL were added to stimulate osteoclast differentiation. 
A. Number of osteoclasts per well is presented as mean +/- standard deviation. B, C & D. 
Morphology of osteoclast cell cultures in the first (B), second (C) and third (D) week after the 
fracture under 100× magnification. Osteoclasts are TRAP positive (purple) cells with 3 or 
more nuclei. * denotes a statistically significant difference at p <0,05. 
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Figure 4. Osteoclastogenic potential of cells from bone marrow of femur three weeks 
after the tibial fracture (‘FR’), sham procedure (‘PIN CONTROL’) or in control group in 
B6, Fas -/-, and FasL -/- mice. Cell suspensions were made by combining bone marrow of 
femurs of 2 mice per strain. Cells were cultured in 96 well plate at density 0,25×10
6
 cell per 
well. 20ng/ml rmM-CSF and 40ng/ml rmRANKL were added to stimulate osteoclast 
differentiation. Number of osteoclasts per well is presented as mean +/- standard deviation. * 
denotes a statistically significant difference at p <0,05. 
1.3. Effect of loss of functional Fas receptor or Fas ligand (FasL) on 
osteoclastogenic potential of peripheral blood 
Blood from Fas -/- mice had lower osteoclastogenic potential than B6 and 
FasL -/- in the first week after the tibial fracture. In week 2 and week 3, the 
number of osteoclasts per well was higher in Fas -/- than in B6 and FasL-/-. 
FasL -/- blood had a higher number of differentiated osteoclasts in cultures 
than B6 control in the first week, but lower than the control in week 2. (Figure 
5) 
 
When the number of osteoclasts per well was compared between the animals 
with fractured tibiae and those from the control and pin control group, there 
was a higher number of osteoclasts per well in the cultures of mice that had 
the tibial fracture, than in pin control and control group in B6 and Fas -/-. In 
FasL-/-, number of osteoclasts per well was higher in the control group than in 
fracture and pin control (Figure 6).  
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Figure 5. Osteoclastogenic potential of cells from peripheral blood 1, 2, and 3 weeks 
after the fracture. Cell suspensions were made by combining blood samples obtained from 2 
mice per strain. Cells were cultured in 96 well plate at density 0,25×10
6
 cell per well. 20ng/ml 
rmM-CSF and 40ng/ml rmRANKL were added to stimulate osteoclast differentiation. A. 
Number of osteoclasts per well is presented as mean +/- standard deviation. B, C & D. 
Morphology of osteoclast cell cultures in the first (B), second (C) and third (D) week after the 
fracture under 100× magnification. Osteoclasts are TRAP positive purple cells with 3 or more 
nuclei. * denotes a statistically significant difference at p <0,05. 
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Figure 6. Osteoclastogenic potential of cells from peripheral blood three weeks after 
the fracture procedure (‘FR’), sham procedure (‘PIN CONTROL’) or in control group in 
B6, Fas -/-, and FasL -/- mice. Cell suspensions were made by combining blood samples 
obtained from 2 mice per strain. Cells were cultured in 96 well plate at density 0,25×10
6
 cell 
per well. 20ng/ml rmM-CSF and 40ng/ml rmRANKL were added to stimulate osteoclast 
differentiation. Number of osteoclasts per well is presented as mean +/- standard deviation. * 
denotes a statistically significant difference at p <0,05. 
2. Histological analysis 
Histological sections of tibiae, fractured and those from the pin control group, 
were stained for tartrate-resistant acid phosphatase (TRAP) enzyme activity 
to identify and count osteoclasts on bone or cartilage surfaces. The number of 
osteoclasts per bone surface (N.Oc) and percent of eroded surface (ES%) 
was determined on trabeculae of newly formed callus, trabeculae outside of 
the callus area and below the cortical bone, to evaluate how the fracture 
influenced the number of osteoclasts on those surface and how this number 
was influenced by loss of Fas receptor or its ligand, FasL. Osteoclasts 
adjacent to cartilaginous surface were also counted on epiphyseal cartilage 
and on cartilage formed in fracture callus.  
Changes in number of osteoclasts per bone or cartilage surface and percent 
of eroded surface were analyzed at three different timepoints following the 
fracture or sham procedure – 1, 2, and 3 weeks after.  
2.1. Healing of controlled tibial fractures occurred through 
endochondral ossification 
Histology showed that healing occurred through endochondral ossification in 
all three strains (B6, Fas -/-, and FasL -/-). In the first week after the fracture, 
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undifferentiated mesenchymal tissue was predominant in fracture calluses of 
all three mouse strains (Figure 7). Cartilage tissue was also abundant, and 
bony trabeculae were evident at some parts of the callus with few TRAP 
positive osteoclasts on their surface. In the second week, fracture callus was 
composed of hyaline cartilage and newly formed bony trabeculae (Figure 8). 
Numerous TRAP positive osteoclasts were observed on the trabeculae. In the 
third week, cartilage tissue (soft callus) was replaced by trabecular bone 
which formed the hard callus (Figure 9). 
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Figure 7. Histological presentation of fracture healing in the first week after the 
fracture in B6, Fas -/-, and FasL -/- tibiae. Representative sections of fracture calluses of 
tibiae under 25× magnification stained with Goldner-trichrome stain. 
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Figure 8. Histological presentation of fracture healing in the second week after the 
fracture in B6, Fas -/-, and FasL -/- tibiae. Representative sections of fracture calluses of 
tibiae under 25× magnification stained with Goldner-trichrome stain. 
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Figure 9. Histological presentation of fracture healing in the third week after the 
fracture in B6, Fas -/-, and FasL -/- tibiae. Representative sections of fracture calluses of 
tibiae under 25× magnification stained with Goldner-trichrome stain. 
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2.2. Effect of loss of Fas or FasL on the number of osteoclasts and 
percent of eroded surface on trabecular bone of tibiae 
2.2.1. Trabeculae of fracture callus  
The number of osteoclasts on trabeculae of fractured callus was lowest in the 
first week after the fracture. At that time point, tibiae of B6, Fas -/- and FasL -/- 
showed no significant difference (Figure 11). The number doubled in the 
second week after the fracture in Fas -/- and FasL -/- tibiae, but did not 
significantly change in the B6 control group (Figure 10). The number of 
osteoclasts at that time point (week 2) was significantly higher in the knockout 
strains than in the control group (Figure 12). The number of osteoclasts per 
bone surface in the knockout strains (Fas -/- and FasL -/-) did not change 
from second to third week (Figure 10). Mice from B6 control group showed 
and increase in number of osteoclasts from 2 to 3 week (Figure 10). In the 
third week, the number was not statistically different from knockout strains 
(Figure 13).  
 
 
Figure 10. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae of fracture callus during three time 
points (week 1, week 2, and week 3) after the fracture of B6 control, Fas -/-, and FasL -/- 
tibiae. The number of TRAP positive osteoclasts is counted per mm of bone surface and 
presented as their mean value.  
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Figure 11. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae of fracture callus in the first week 
after the fracture of B6 control, Fas -/-, and FasL -/- tibiae. A. Representative sections of 
trabeculae in callus of fractured tibiae of B6, Fas -/- and FasL -/- mice in the first week after 
the fracture under 200× magnification stained with TRAP. Arrows denote TRAP positive 
osteoclasts. B. The number of TRAP positive osteoclasts is counted per mm of bone surface. 
Number of osteoclasts /mm and percent of eroded surface are presented as mean +/- 
standard deviation. * denotes a statistically significant difference at p <0,05. 
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Figure 12. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae of fracture callus in the second 
week after the fracture of B6 control, Fas -/-, and FasL -/- tibiae. A. Representative 
sections of trabeculae in callus of fractured tibiae of B6, Fas -/-, and FasL -/- mice in the 
second week after the fracture under 200× magnification stained with TRAP. Arrows denote 
TRAP positive osteoclasts. B. The number of TRAP positive osteoclasts is counted per mm of 
bone surface. Number of osteoclasts / mm and percent of eroded surface are presented as 
mean +/- standard deviation. * denotes a statistically significant difference at p <0,05. 
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Figure 13. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae of fracture callus in the third week 
after the fracture of B6 control, Fas -/- and FasL -/- tibiae. A. Representative sections of 
trabeculae in callus of fractured tibiae of B6, Fas -/- and FasL -/- mice in the third week after 
the fracture under 200× magnification stained with TRAP. Arrows denote TRAP positive 
osteoclasts. B. The number of TRAP positive osteoclasts is counted per mm of bone surface. 
Number of osteoclasts / mm and percent of eroded surface are presented as mean +/- 
standard deviation. * denotes a statistically significant difference at p <0,05. 
.  
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2.2.2. Trabeculae outside of callus area 
In the fractured tibiae of Fas -/- and FasL -/- mice, trabeculae of tibiae outside 
of callus did not show significant differences in the number of osteoclasts per 
bone surface and in percent of eroded surface between different time points. 
In the fractured tibiae of B6 control mice, there was a slight difference in the 
number of osteoclasts per surface between the first and second week, and a 
slight difference between eroded surface between the third and second week.  
The three different strains differed only by the number of osteoclasts per bone 
surface in the first week after the fracture, when B6 control mice had a higher 
number of osteoclasts than Fas and FasL knockout mice. At other time points, 
there were no significant differences between strains for both N.Oc and %ES. 
(Figure 14) 
 
When fractured tibiae were compared to tibiae of the pin control group, 
fractured tibiae of B6 control mice had and a higher number of osteoclasts on 
bone surface in first and second week, but lower in the third week. Similar 
changes were observed with percent of eroded surface. Fas -/- mice showed 
no difference between the fractured and pin control tibiae, except for a slightly 
higher number of osteoclasts per surface in the pin control tibiae in the first 
week. FasL -/- mice had a higher number of osteoclasts per surface and a 
higher percentage of eroded surface in the pin control tibiae in second week 
after the fracture. This difference was not observed at other time points. 
(Figure 15, 16, 17) 
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Figure 14. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae outside of fracture callus in the 
first, second and third week after the fracture of B6 control, Fas -/- ,and FasL -/- tibiae. 
A & B. The number of TRAP positive osteoclasts is counted per mm of bone surface. Number 
of osteoclasts /mm and percent of eroded surface are presented as mean +/- standard 
deviation. C. Representative sections of fractured tibiae of B6, Fas -/-, and FasL -/- mice in 
the first week after the fracture under 200× magnification stained with TRAP. Arrows denote 
TRAP positive osteoclasts. * denotes a statistically significant difference at p <0,05. 
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Figure 15. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae outside of fracture callus in the 
fractured (FR) and pin control (PC) tibiae in the first week after the fracture of B6 
control, Fas -/-, and FasL -/- tibiae. The number of TRAP positive osteoclasts is counted per 
mm of bone surface and presented as mean +/- standard deviation. * denotes a statistically 
significant difference at p <0,05. 
  
 33 
Figure 16. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae outside of fracture callus in the 
fractured (FR) and pin control (PC) tibiae in the second week after the fracture of B6 
control, Fas -/- and FasL -/- tibiae. The number of TRAP positive osteoclasts is counted per 
mm of bone surface and presented as mean +/- standard deviation. * denotes a statistically 
significant difference at p <0,05. 
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Figure 17. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on the trabeculae outside of fracture callus in the 
fractured (FR) and pinc control (PC) tibiae in the third week after the fracture of B6 
control, Fas -/- and FasL -/- tibiae. The number of TRAP positive osteoclasts is counted per 
mm of bone surface and presented as mean +/- standard deviation. * denotes a statistically 
significant difference at p <0,05. 
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2.2.3. Comparison of trabeculae outside the callus area and newly 
formed trabeculae in callus 
Number of osteoclasts (N.Oc) and eroded surface (%ES) were measured and 
compared on trabecular bone outside of callus and on trabeculae of newly 
formed callus. In the first week after the fracture, the number of osteoclasts 
per bone surface was significantly higher on the trabeculae that were not in 
fracture callus than on newly formed trabeculae of fracture callus in all mouse 
strains (Figure 18). In the second week, the number stayed higher only in the 
B6 control group, while it was the same and lower in Fas -/- and FasL -/- mice, 
respectively (Figure 19). In the third week, there were no significant 
differences (Figure 20). 
The percent of eroded surface followed a similar fashion – the percentage 
was significantly lower on the trabeculae of fracture callus in all three stranis 
in the first week (Figure 18). In second week, this percentage stayed higher 
only in the B6 control group, while there was no difference between 
trabecullae in and out of callus in the knockout strains (Figure 19). In the third 
weeks, there were no differences, except of a sight increase in the eroded 
surface on traeculae of callus of FasL -/- tibiae (Figure 20).  
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Figure 18. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on trabeculae of fracture callus and trabeculae 
outside of callus in the first week after the fracture of B6 control, Fas -/- ,and FasL -/- 
tibiae. The number of TRAP positive osteoclasts is counted per mm of bone surface and 
presented as mean +/- standard deviation. * denotes a statistically significant difference at p 
<0,05. 
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Figure 19. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on trabeculae of fracture callus and trabeculae 
outside of callus in the second week after the fracture of B6 control, Fas -/-, and FasL -
/- tibiae. The number of TRAP positive osteoclasts is counted per mm of bone surface and 
presented as mean +/- standard deviation. * denotes a statistically significant difference at p 
<0,05. 
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Figure 20. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on trabeculae of fracture callus and trabeculae 
outside of callus in the third week after the fracture of B6 control, Fas -/-, and FasL -/- 
tibiae. The number of TRAP positive osteoclasts is counted per mm of bone surface and 
presented as mean +/- standard deviation. * denotes a statistically significant difference at p 
<0,05. 
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2.2.4. Subcortical bone 
The number of osteoclasts per surface of subcortical bone of fractured tibiae 
was the lowest in the first week after the fracture in all strains. The number 
increased in the second week, but the difference was statistically significant 
only in Fas -/- and FasL -/-. The number stayed high in the third week in B6 
control and Fas -/- fractured tibiae, but decreased to values similar to those 
from first week in FasL -/- mice. Eroded surface followed a similar fashion, but 
the differences between weeks were only significant in fractured tibiae of Fas 
-/- mice (Figure 21). 
There were no differences between number of osteoclasts on bone surfaces 
and percentage of eroded surface at first and second week after the fracture, 
but in the third week, B6 control mice had a significantly higher number of 
osteoclasts per subcortical bone than the knockout strains and a higher 
percentage of eroded surface than FasL -/- mice. The knockout strains also 
differed between each other in the third week – Fas -/- mice had both higher 
number of osteoclasts per bone surface and a hiher percentage of eroded 
surface than FasL -/- mice. (Figure 22) 
 
 
Figure 21. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on subcortical bone in fractured tibiae 1, 2 and 3 
weeks after the fracture in B6, Fas -/- and FasL -/- mice. The number of TRAP positive 
osteoclasts is counted per mm of bone surface and presented as mean +/- standard 
deviation. * denotes a statistically significant difference at p <0,05. 
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Figure 22. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) and 
percent of eroded surface (%ES) on subcortical bone in fractured tibiae 1, 2 and 3 
weeks after the fracture in B6, Fas -/- ,and FasL -/- mice. A & B. The number of TRAP 
positive osteoclasts is counted per mm of bone surface. Number of osteoclasts / mm and 
percent of eroded surface are presented as mean +/- standard deviation. C. Representative 
sections of fractured tibiae of B6, Fas -/- and FasL -/- mice in the third week after the fracture 
under 200x magnification stained with TRAP. Arrows denote TRAP positive osteoclasts. * 
denotes a statistically significant difference at p <0,05. 
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2.3. Effect of loss of Fas and FasL on the number of osteoclasts on 
cartilage surface  
The number of osteoclasts per cartilage surface were counted adjacent to the 
epiphyseal (growth plate) cartilage and in the fracture callus in the second 
week after the fracture. 
The number of osteoclasts per epiphyseal cartilage surface of fractured tibiae 
did not differ between Fas -/-, FasL -/- ad B6 control mice at any time point 
after the fracture, and did not significantly change between different time 
points, except in FasL -/- tibiae when the number of osteoclasts was slightly 
higher in second week after the fracture. (Figure 23) 
When mice from the pin control group were compared to mice from the 
fracture group, there were no significant differences between numbers of 
osteoclasts adjacent to growth plate cartilage, except of lower numbers of 
osteoclast per cartlage surface fractured tibiae of B6 control mice in the first 
and second week and in FasL -/- mice in third week after the fracture. (Figure 
24) 
Number of osteoclast per cartilage surface in the knockout strains (Fas -/- and 
FasL -/-) in the fracture callus second week after the fracture did not 
significantly differ from the B6 control group. (Figure 25) 
Comparison of cartilage surface on the growth plate of fractured tibiae and 
cartilage in fracture callus showed there were no significant differences 
between the numbers of osteoclasts on cartilage surfaces. (Figure 26) 
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Figure 23. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) on 
cartilage surface of epiphyseal plates of fractured tibiae in B6, Fas -/- and FasL -/- mice 
at 1, 2 and 3 weeks after the fracture. A. Representative sections of epiphyses of fractured 
tibiae of B6, Fas -/- and FasL -/- mice in the first week after the fracture under 200x 
magnification stained with TRAP. Picture shows growth plate cartilage. Arrows denote TRAP 
positive osteoclasts. B. The number of TRAP positive osteoclasts is counted per mm of 
cartilage surface and presented as mean +/- standard deviation. * denotes a statistically 
significant difference at p <0,05. 
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Figure 24. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) on 
cartilage surface of epiphyseal plates of fractured tibiae compared to tibiae of pin 
control group of B6, Fas -/- and FasL -/- mice at 1, 2 and 3 weeks after the fracture. The 
number of TRAP positive osteoclasts is counted per mm of cartilage surface and presented 
as mean +/- standard deviation. * denotes a statistically significant difference at p <0,05. 
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Figure 25. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) on 
cartilage surface in the fracture calluses of tibiae in the second week after the fracture 
in B6, Fas -/- and FasL -/- mice. A. Representative sections of callus of fractured tibiae of 
B6, Fas -/- and FasL -/- mice in the second week after the fracture under 200x magnification 
stained with TRAP. Picture shows hyaline cartilage present in the fracture callus. Arrows 
denote TRAP positive osteoclasts. B. The number of TRAP positive osteoclasts is counted 
per mm of cartilage surface and presented as mean +/- standard deviation. * denotes a 
statistically significant difference at p <0,05. 
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Figure 26. Histological analysis of the number of TRAP positive osteoclasts (N.Oc) on 
cartilage surface in the fracture calluses of tibiae in the second week after the fracture 
and the number of osteoclasts on surface of growth plate cartilage at that time point in 
B6, Fas -/-, and FasL -/- mice. The number of TRAP positive osteoclasts is counted per mm 
of cartilage surface and presented as mean +/- standard deviation. * denotes a statistically 
significant difference at p <0,05. 
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DISCUSSION 
It has been previously described that the Fas/FasL apoptotic system 
has an influence on osteoclast life span and differentiation and plays a role in 
regulation of bone homeostasis (Katavic et al. 2003, Wu et al. 2003, Roux et 
al. 2005, Wang et al. 2015, Park et al. 2005b). With our experiment, we tried 
to define the role of Fas/FasL system on osteoclatsogenesis in vitro and in 
vivo. 
By culturing osteoclast progenitor cells from bone marrow and blood, 
we tried to define the influence of loss of Fas and FasL on the in vitro ability of 
those progenitors to differentiate into mature osteoclast as well as evaluate 
the influence of fracture on their differentiation in B6 control and Fas and FasL 
deficient phenotypes. Other studies have shown that a spontaneous mutation 
of FasL (in gld mice) does not alter the potential of bone marrow progenitors 
in comparison to the control groups, but a complete loss of functional Fas 
receptor in Fas knockout (Fas -/-) mice caused a higher osteoclastogenic 
potential in comparison to the control (Kovacic et al. 2007). 
When Fas -/- and FasL -/- mice were compared with B6 control in this 
experiment, osteoclast cell cultures showed differences between strains that 
were difficult to interpret at almost all time points in all three samples; bone 
marrow of tibiae, bone marrow of femurs, and blood. We also tried to evaluate 
the effect of the fracture procedure on the ability of progenitors to differentiate 
into mature osteoclasts. In bone marrow of tibiae, the fracture procedure 
caused lower osteoclastogenic potential of progenitor cells than the potential 
of those who’s tibias were not fractured (the control group), but this was not 
apparent in bone marrow of femurs and blood. Since it was difficult to find an 
explanation for our results, the experiment should be repeated in order to be 
able to correctly interpret the differences between strains. 
Histological analysis of fractured and pin control tibiae from B6, Fas -/-, 
and FasL -/- mice allowed us to evaluate the effect of loss of the death 
receptor or its ligand on osteoclastogenesis in vivo. Sections of tibiae were 
analyzed to see how loss of Fas an FasL affected the number of osteoclasts 
at different stages of fracture healing and to provide an insight to how the 
fracture itself influenced the measured parameters, by comparing the 
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fractured tibiae to the ones that only had the stainless steel wire inserted (pin 
control group). The model of controlled tibial fracture was used since fracture 
healing recapitulates the embryonic processes that occur during bone 
formation (Ferguson et al. 1999) and follows steps of endochondral 
ossification if there is some degree of mechanical instability present during the 
fracture healing process (Einhorn & Gerstenfeld 2015, Schindeler et al. 2008). 
In our experiment, histological observations of fractured tibiae confirmed that 
fracture healing occurred through a typical endochondral ossification pathway 
in B6, Fas -/-, and FasL -/- mice. Fracture calluses in the first and second 
week after the fracture showed abundant cartilage tissue. Bone formation was 
evident even in the first week, and newly formed trabeculae were evident at 
multiple sites in the callus. This early occurrence of bony trabeculae (by day 7 
after the fracture) has also been described by Manigrasso et al in the 
C57BL/6 strain (Manigrasso & O'Connor 2008). The cartilage tissue was 
almost completely replaced by bone in the third week in all fracture groups.  
Fracture healing proceeds through several steps – an initial 
inflammatory stage with hematoma formation that happens early after the 
fracture (happens earlier than our earliest time-points and, hence, was not 
observed in our experiment); a proliferative stage with soft and hard callus 
formation and the remodeling stage (Schindeler et al. 2008); and a resorptive 
phase. The phases of healing can also be defined as anabolic and catabolic. 
The catabolic phase, caused by osteoclast activity, starts with cartilage 
resorption and then continues through primary bone resorption and the 
remodeling of the callus (Einhorn & Gerstenfeld 2015). We analyzed the 
fracture calluses for numbers of osteoclasts on the surfaces of newly formed 
trabeculae, to see how the loss of the Fas system affected those cells during 
the period of new bone formation. As expected, the lowest numbers of 
osteoclasts on bone surfaces were found in the first week, when the bone was 
not that abundant yet. The numbers did not differ between B6 control and the 
knockout strains (Fas -/- and FasL -/-), indicating that loss of Fas receptor or 
its ligand did not cause a change at this time point. It has been previously 
proposed that loss of functional Fas signaling does not appear to alter early 
callus development, but causes differences in the later stages of removal of 
cartilage and remodeling of bone (Al-Sebaei et al. 2014). The number of 
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osteoclasts and the percent of eroded bone surface both almost doubled by 
the second week and stayed at this level until the third week in tibiae with no 
functional Fas signaling (Fas -/- and FasL -/- mice). In the B6 control, the 
number in the second week was approximately the same as in first week, but 
then increased in the third week, showing that the increase in osteoclast 
numbers occurred later when Fas signaling was normal and suggesting that 
the remodeling of the fracture calluses started early when there was no Fas 
signaling. Al-Sebaei et al (Al-Sebaei et al. 2014) also described a higher 
number of osteoclasts in second week calluses in lpr mice compared to the 
controls. It is also possible that the parts of the calluses that were visible on 
the sections were not representative in the B6 controls, because of the small 
number of samples used, since there should be some increase in remodeling 
observed by the second week after the fracture. Outside of the callus, on the 
same tibiae, the number of osteoclasts on the trabeculae in the second and 
third week did not differ between the B6 control group and Fas -/-, and FasL -
/- mice, indicating that if this change that occurred in the second week with 
loss of functional Fas signaling was correctly observed, it only occurred during 
new bone formation. 
We also compared osteoclast numbers in the callus to the numbers on 
the trabecular bone outside of the callus. In the first week, we found that the 
number of osteoclasts in calluses are lower, indicating there was almost no 
resorption going on in the callus at this time point. The same change was 
evident even in the second week in the B6 calluses, consistent with the result 
that there was no increase in the number of osteoclasts in callus at this time 
point, but not in the calluses where Fas signaling was dysfunctional – the 
numbers of osteoclasts have increased there, as was also described before. 
There were only rare differences between number of osteoclasts and the 
percent of eroded surface in callus and on trabecular bone outside of callus at 
the third week in B6 control and at second and third week in knockout strains, 
suggesting that the resorption in the callus was of the same intensity as the 
resorption of bone not involved in the fracture healing, or that the healing 
process caused an increase in osteoclasts at both locations. 
When trabeculae outside of callus of fractured tibiae were compared to 
tibiae of the pin control group, there were slight differences between them in 
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all three strains at different time points that were difficult to explain. Fractured 
tibiae of B6 control mice had a higher number of osteoclasts on bone surface 
in first and second week, but lower in the third week, suggesting that the 
fracture is responsible for the increase in the number of osteoclasts in the 
early (first 2 weeks) stages of fracture healing. Similar change was not evident 
in the knockout strains. The differences might be due to the fact that the 
insertion of the pin also caused some trauma to the bones (in both fracture 
and pin control groups) and evoked a response with new bone formation and 
remodeling at those places.  
We also observed the osteoclasts below the cortical bone, where there 
was an increase in the number of osteoclasts from the first to second week 
after the fracture in the control and the Fas and FasL deficient groups, 
indicating that the start of the remodeling in the fracture calluses also caused 
a certain increase in the number of osteoclasts on cortical bone, that was not 
dependent on Fas signaling.  
When hypertrophic chondrocytes die by apoptosis during endochondral 
ossification, osteoclasts are responsible for the removal of the cartilaginous 
matrix (Einhorn & Gerstenfeld 2015, Gerstenfeld et al. 2003) and can be 
observed on the cartilaginous surfaces on histological sections. Cartilage 
surfaces at two places in the fractured tibiae were analyzed in our experiment 
– at the border between the epiphysis and diaphysis of the bone, where 
hyaline cartilage forms the epiphyseal plate and is responsible for bone 
growth (Mescher 2013), and in the fracture calluses, where the surface was 
particularly well defined in the second week after the fracture, when 
osteoclasts were numerous on the borders where cartilage is being replaced 
by bone. It is evident from our results, that the loss of Fas or FasL did not 
influence the number of osteoclasts on any of the cartilage surfaces. The 
numbers on cartilage of week 2 calluses were not different between strains. 
When comparing the numbers of osteoclasts on the border of cartilage 
surface on growth plate and in second week, the analysis also showed no 
significant differences, suggesting that the resorption of cartilaginous matrix 
by osteoclasts was the same in the epiphyses as in the fracture callus and 
that Fas signaling had no apparent influence on the number of osteoclasts 
present on cartilaginous surfaces during new bone formation by endochondral 
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ossification. Comparison of the fracture and pin control groups showed that 
the numbers on the growth plate were only mildly influenced by the fracture 
procedure, which caused an increase only at two time points in B6 control and 
one on FasL. This may be attributed to the fact that the pin also caused 
trauma to the growth plate and caused a change in the number of osteoclasts 
on the surfaces.  
To further evaluate the role of Fas and FasL on osteoclastogenesis 
and the behavior and activity of osteoclasts, it would be necessary to analyze 
the parameters describing trabecular bone morphology (trabecular thickens, 
number and separation) by histomorphometric or micro CT analysis and 
explore the gene expression of osteoclast-specific genes at different time 
points, but this was beyond the scope of this research. 
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CONCLUSIONS 
In the in vitro part of the experiment, our conclusion was that repetition of the 
experiment would be necessary to correctly define the role of Fas/FasL 
pathway on osteoclastogenic potential of bone marrow of tibiae, femur and 
peripheral blood in the model of controlled tibial fracture. 
 
In the in vivo part, we observed that the fracture healing occurred by 
endochondral ossification. We concluded that an increase in the number of 
osteoclasts on trabeculae in fracture calluses occurred earlier, in the second 
week after the fracture, when Fas signaling was dysfunctional, whereas in the 
control groups, it was observed in the third week. We also concluded that 
Fas/FasL system has no apparent role in regulation of number of osteoclasts 
resent on cartilage surfaces of growth plate and the week 2 fracture callus. 
 
Our conclusion was that Fas/FasL system has a role in osteoclastogenesis 
during new bone formation in fracture healing, but further research is 
necessary to correctly interpret its exact function. 
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